deltatrials
Completed NA INTERVENTIONAL 2-arm NCT00481026

A Double Blind Sham Controlled Trial of tDCS in Treating Schizophrenia and Depression

Sponsor: Bayside Health

Updated 6 times since 2017 Last updated: Oct 11, 2020 Started: Aug 31, 2007 Primary completion: May 31, 2013 Completion: May 31, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Major Depression and Schizophrenia and is currently completed. Bayside Health leads this study, which shows 6 recorded versions since 2007 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotUnknown Status~Jun 2018 – ~Nov 2020 · 29 months · monthly snapshotUnknown Status~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Nov 2020 — Jan 2021 [monthly]

    Completed NA

    Status: Unknown StatusCompleted

  5. Jun 2018 — Nov 2020 [monthly]

    Unknown Status NA

Show 1 earlier version
  1. Jan 2017 — Jun 2018 [monthly]

    Unknown Status NA

    First recorded

Aug 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bayside Health
Data source: Bayside Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations